British drugmaker AstraZeneca plans to spend $200 million over the next three years, expanding its manufacturing facility in Frederick, Md., and hiring an additional 300 workers at the site, executives said.
The decision further cements Gaithersburg-based MedImmune, an AstraZeneca company, as the crown jewel of Maryland’s life sciences industry.
{iframe}http://www.washingtonpost.com/business/capitalbusiness/drugmaker-astrazeneca-expands-footprint-in-maryland-plans-to-hire-300-workers/2014/11/24/0ae67722-73fd-11e4-a589-1b102c2f81d0_story.html{/iframe}